Global Permanent Birth Control Drugs Overview
Permanent birth control drugs are drug that contain hormones which stops the eggs from releasing in females or stop ovulation. It is also called fertility control and contraceptives. Increase in awareness about the family planning and unintended pregnancy is the major factor driving the growth of the global market.
North America region dominates the market in terms of revenue due to increasing awareness about the sexually transmitted diseases especially in countries like US and Canada.
Permanent birth control drugs market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global permanent birth control drugs market report segments the market on the basis of marketed drug, mechanism of drugs, age group, education, end-user, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global permanent birth control drugs market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Key players in the global permanent birth control drugs market include,
- The Female Health Company
- Allergan plc
- Teva Pharmaceutical Industries Limited
- Bayer AG, Pfizer, Inc
- Cooper Companies, Inc
- Mayer Laboratories
- Ansell LTD., Merck & Co., Inc
- Church & Dwight, Co., Inc.
Prophecy Market Insights offers required customization on this report according to specific business requirements.
Global Permanent Birth Control Drugs Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drugs
- Market Snippet, By Age Group
- Market Snippet, By END USER
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Implantable Pulse Generator Market, By Drugs, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Oral Contraceptives (Combined Contraceptives and Mini-pills
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contraceptive Injectable
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Topical Contraceptive Patch
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Implantable Pulse Generator Market, By Age Group, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- 15-24 years
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- 25-34 years
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- 35-44 years
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Above 44 years
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Implantable Pulse Generator Market, By END USER, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Household
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Implantable Pulse Generator Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Drugs, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Drugs, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Drugs, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Drugs, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Drugs, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By END USER, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- The Female Health Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Allergan plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Teva Pharmaceutical Industries Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cooper Companies, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mayer Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Ansell LTD
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co., Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Church & Dwight, Co., Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global permanent birth control drugs market report segments the market on the basis of marketed drug, mechanism of drugs, age group, education, end-user, and region.
the development of novel contraceptive drug formulations, advancements in long-acting reversible contraceptives (LARCs), and a focus on user-friendly and reversible permanent birth control methods.
the global demand for effective and convenient contraceptive methods, the importance of family planning and reproductive health, and the need for reversible permanent birth control options.
Regions typically considered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The dominance of the market may depend on factors such as regional population demographics, healthcare infrastructure, cultural attitudes towards family planning, and regulatory landscape.
The Female Health Company, Allergan plc, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc, Cooper Companies, Inc, Mayer Laboratories, Ansell LTD., Merck & Co., Inc, Church & Dwight, Co., Inc.,